Cargando…

Establishment of a murine leukaemia cell line resistant to the growth-inhibitory effect of bryostatin 1.

Bryostatin 1 is a novel macrocyclic lactone activator of protein kinase C (PKC) which has clinical potential as an anti-cancer agent. The mechanism of action of this agent is unknown, but protein kinase C has been implicated. In order to investigate this possibility, we have developed P388 sublines...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prendiville, J., McGown, A. T., Gescher, A., Dickson, A. J., Courage, C., Pettit, G. R., Crowther, D., Fox, B. W.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1994
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033429/ https://www.ncbi.nlm.nih.gov/pubmed/7917900

Ejemplares similares

A phase I study of intravenous bryostatin 1 in patients with advanced cancer.
por: Prendiville, J., et al.
Publicado: (1993)

Bryostatin 1-tamoxifen combinations show synergistic effects on the inhibition of growth of P388 cells in vitro.
por: McGown, A. T., et al.
Publicado: (1998)

A phase I trial of bryostatin 1 in patients with advanced malignancy using a 24 hour intravenous infusion.
por: Jayson, G. C., et al.
Publicado: (1995)

A phase II trial of bryostatin 1 in patients with non-Hodgkin's lymphoma
por: Blackhall, F H, et al.
Publicado: (2001)

Effects of bryostatin-1 on chronic myeloid leukaemia-derived haematopoietic progenitors
por: Thijsen, S F T, et al.
Publicado: (1999)

Comparison of daunorubicin and anthrapyrazolone sensitivity and transport in resistant cell lines.
por: McGown, A., et al.
Publicado: (1987)

The interaction with tubulin of a series of stilbenes based on combretastatin A-4.
por: Woods, J. A., et al.
Publicado: (1995)

Metallothionein levels in ovarian tumours before and after chemotherapy.
por: Murphy, D., et al.
Publicado: (1991)

Establishment of murine myeloid-leukaemia cell line in suspension culture.
por: Preisler, H. D.
Publicado: (1978)

Glutathione S-transferase activity and isoenzyme distribution in ovarian tumour biopsies taken before or after cytotoxic chemotherapy.
por: Murphy, D., et al.
Publicado: (1992)

Interaction of the novel agent amphethinile with tubulin.
por: McGown, A. T., et al.
Publicado: (1989)

Comparison of ability of protein kinase C inhibitors to arrest cell growth and to alter cellular protein kinase C localisation.
por: Courage, C., et al.
Publicado: (1995)

Neristatin 1 Provides Critical Insight into Bryostatin 1 Structure–Function Relationships
por: Kedei, Noemi, et al.
Publicado: (2015)

Glutathione-S-transferase activity and isoenzyme levels measured by two methods in ovarian cancer, and their value as markers of disease outcome.
por: Wrigley, E. C., et al.
Publicado: (1996)

Immunohistochemical detection of mutant p53 protein in epithelial ovarian cancer using polyclonal antibody CMI: correlation with histopathology and clinical features.
por: Renninson, J., et al.
Publicado: (1994)

In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug
por: Grosios, K, et al.
Publicado: (1999)

Differential effects of staurosporine analogues on cell cycle, growth and viability in A549 cells.
por: Courage, C., et al.
Publicado: (1996)

Bryostatin analog: improving on Nature's design
por: Boger, Dale
Publicado: (2012)

005 OP: ENTREPRENEURIALISM, ADAPTATION, AND DISCRETION AMONG NURSES IN A TRANSNATIONAL COLLABORATION IN MALAWI AND TANZANIA
por: McGown, M
Publicado: (2017)

Munc13 Is a Molecular Target of Bryostatin 1
por: Blanco, Francisco A., et al.
Publicado: (2019)

Pre-clinical studies of a novel anti-mitotic agent, amphethinile.
por: McGown, A. T., et al.
Publicado: (1988)

A phase II study of bryostatin 1 in metastatic malignant melanoma.
por: Propper, D. J., et al.
Publicado: (1998)

Bryostatin-1: a promising compound for neurological disorders
por: Tian, Zhen, et al.
Publicado: (2023)

Novel heterozygous deletion in the HNF1β gene - adolescent with antibody negative diabetes, longstanding hyperglycaemia without ketosis, cataracts, small echogenic kidneys with a cortical cyst, pancreatic atrophy, exocrine pancreatic insufficiency and a uterine anomaly
por: Conwell, Louise S, et al.
Publicado: (2015)

Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents
por: Marsden, Matthew D., et al.
Publicado: (2018)

“Picolog,” a Synthetically-Available Bryostatin Analog, Inhibits Growth of MYC-Induced Lymphoma In Vivo
por: DeChristopher, Brian A., et al.
Publicado: (2012)

Inhibitory effect of YC8 leukaemia cell line on in vitro lymphocyte reactivity.
por: Biasi, G., et al.
Publicado: (1977)

Sodium Taurocholate Micelles in Fluorometrix Analysis
por: McGown, Linda B., et al.
Publicado: (1988)

Synergistic inhibitory effects of dipyridamole and vincristine on the growth of human leukaemia and lymphoma cell lines.
por: Hirose, M., et al.
Publicado: (1987)

Simplified Bryostatin Analogues Protect Cells from Chikungunya Virus-Induced Cell Death
por: Staveness, Daryl, et al.
Publicado: (2016)

p53 status of newly established acute myeloid leukaemia cell lines
por: Zheng, A, et al.
Publicado: (1999)

Modulation of bryostatin 1 muscle toxicity by nifedipine: effects on muscle metabolism and oxygen supply.
por: Thompson, C. H., et al.
Publicado: (1996)

Growth-inhibitory effects of the chemopreventive agent indole-3-carbinol are increased in combination with the polyamine putrescine in the SW480 colon tumour cell line
por: Hudson, E Ann, et al.
Publicado: (2003)

Designed, Synthetically Accessible Bryostatin Analogues Potently Induce Activation of Latent HIV Reservoirs in vitro
por: DeChristopher, Brian A., et al.
Publicado: (2012)

SUN-270 Heterozygous Mutation in ABCC8 in a Pedigree with Congenital Hyperinsulinism, Multiple Macrosomic Stillbirths, and Adult-Onset Diabetes Mellitus
por: Ludwig, Karissa, et al.
Publicado: (2019)

Phorbol ester and bryostatin effects on growth and the expression of oestrogen responsive and TGF-beta 1 genes in breast tumour cells.
por: Nutt, J. E., et al.
Publicado: (1991)

Chronic bryostatin-1 rescues autistic and cognitive phenotypes in the fragile X mice
por: Cogram, Patricia, et al.
Publicado: (2020)

ZNStress: a high-throughput drug screening protocol for identification of compounds modulating neuronal stress in the transgenic mutant sod1G93R zebrafish model of amyotrophic lateral sclerosis
por: McGown, Alexander, et al.
Publicado: (2016)

A multicentre phase II trial of bryostatin-1 in patients with advanced renal cancer
por: Madhusudan, S, et al.
Publicado: (2003)

Influence of Hormones and Chemical Carcinogen on Murine Leukaemia
por: Karande, K. A., et al.
Publicado: (1973)

Cannot write session to /tmp/vufind_sessions/sess_68s5egp0fbcgf96tc6ta687gl1